How Can S6K1 be Targeted for Therapeutic Purposes?
Given its involvement in various diseases, S6K1 is considered a potential therapeutic target. Inhibitors of S6K1 activity are being explored for their potential to treat cancer by reducing tumor growth and proliferation. Additionally, modulating S6K1 activity could improve insulin sensitivity in diabetic patients and provide neuroprotection in neurodegenerative disorders.
